Literature DB >> 1382784

Effect of the beta-adrenoceptor agonist clenbuterol and phytohaemagglutinin on growth, protein synthesis and polyamine metabolism of tissues of the rat.

S Bardocz1, D S Brown, G Grant, A Pusztai, J C Stewart, R M Palmer.   

Abstract

1. The kidney bean lectin, phytohaemagglutinin (PHA), induced a marked atrophy of skeletal muscle which was evident from the changes in tissue composition (protein, RNA, DNA and polyamine content) and from the reduction in weight and protein synthesis of hind leg muscles of rats fed on kidney bean-diets for four days. The beta-adrenoceptor agonist, clenbuterol, induced skeletal muscle hypertrophy by transiently stimulating protein synthesis. As a consequence, the muscle loss caused by a short exposure to PHA was, in part, ameliorated by clenbuterol treatment. 2. Cardiac muscle was affected to a lesser extent than skeletal muscle by both clenbuterol and the lectin. However, there was evidence that protein synthesis in heart was reduced by PHA. 3. PHA had opposite effects on the gut, the lectin-induced hyperplasia of the jejunum was accompanied by a large increase in protein synthesis. Clenbuterol alone had no effect on the jejunum whereas a combination of PHA and clenbuterol appeared to exacerbate the effect of the lectin on gut. 4. Both the lectin-induced gut growth and the hypertrophy of skeletal muscle caused by clenbuterol were preceded by the accumulation of polyamines in the respective tissues. Of particular note was the observation that a significant increase in the proportion of the intraperitoneally injected 14C-labelled spermidine or putrescine taken up by the growing tissues could be detected by the second day. Therefore, the measurement of uptake of labelled polyamines may be used as a sensitive indicator of early alterations in tissue metabolism.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1382784      PMCID: PMC1907496          DOI: 10.1111/j.1476-5381.1992.tb14359.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  19 in total

1.  Polyamine metabolism and uptake during Phaseolus vulgaris lectin, PHA-induced growth of rat small intestine.

Authors:  S Bardócz; G Grant; D S Brown; S W Ewen; I Nevison; A Pusztai
Journal:  Digestion       Date:  1990       Impact factor: 3.216

2.  The relative importance of muscle protein synthesis and breakdown in the regulation of muscle mass.

Authors:  D J Millward; P J Garlick; D O Nnanyelugo; J C Waterlow
Journal:  Biochem J       Date:  1976-04-15       Impact factor: 3.857

3.  Luminal and basolateral polyamine uptake by rat small intestine stimulated to grow by Phaseolus vulgaris lectin phytohaemagglutinin in vivo.

Authors:  S Bardocz; D S Brown; G Grant; A Pusztai
Journal:  Biochim Biophys Acta       Date:  1990-04-23

Review 4.  Polyamines in rapid growth and cancer.

Authors:  J Jänne; H Pösö; A Raina
Journal:  Biochim Biophys Acta       Date:  1978-04-06

5.  Stimulation of muscle growth by clenbuterol: lack of effect on muscle protein biosynthesis.

Authors:  P J Reeds; S M Hay; P M Dorwood; R M Palmer
Journal:  Br J Nutr       Date:  1986-07       Impact factor: 3.718

6.  Muscle proteolysis induced by a circulating peptide in patients with sepsis or trauma.

Authors:  G H Clowes; B C George; C A Villee; C A Saravis
Journal:  N Engl J Med       Date:  1983-03-10       Impact factor: 91.245

7.  The action of the beta-agonist clenbuterol on protein metabolism in innervated and denervated phasic muscles.

Authors:  C A Maltin; S M Hay; M I Delday; G E Lobley; P J Reeds
Journal:  Biochem J       Date:  1989-08-01       Impact factor: 3.857

8.  Effects of the cyclo-oxygenase inhibitor, fenbufen, on clenbuterol-induced hypertrophy of cardiac and skeletal muscle of rats.

Authors:  R M Palmer; M I Delday; D N McMillan; B S Noble; P Bain; C A Maltin
Journal:  Br J Pharmacol       Date:  1990-12       Impact factor: 8.739

9.  The effects of endotoxaemia on protein metabolism in skeletal muscle and liver of fed and fasted rats.

Authors:  M M Jepson; J M Pell; P C Bates; D J Millward
Journal:  Biochem J       Date:  1986-04-15       Impact factor: 3.857

10.  Chronic effects of beta 2-adrenergic agonists on body composition and protein synthesis in the rat.

Authors:  P W Emery; N J Rothwell; M J Stock; P D Winter
Journal:  Biosci Rep       Date:  1984-01       Impact factor: 3.840

View more
  7 in total

Review 1.  Androgens and skeletal muscle: cellular and molecular action mechanisms underlying the anabolic actions.

Authors:  Vanessa Dubois; Michaël Laurent; Steven Boonen; Dirk Vanderschueren; Frank Claessens
Journal:  Cell Mol Life Sci       Date:  2011-11-19       Impact factor: 9.261

2.  Dietary putrescine effects on performance parameters, nutrient digestibility, intestinal morphology and tissue polyamine content of broilers fed low protein diet.

Authors:  S M Hashemi; T C Loh; H L Foo; I Zulkifli; M Hair-Bejo
Journal:  Iran J Vet Res       Date:  2014       Impact factor: 1.376

3.  Transepithelial transport of putrescine across monolayers of the human intestinal epithelial cell line, Caco-2.

Authors:  V Milovic; L Turchanowa; J Stein; W F Caspary
Journal:  World J Gastroenterol       Date:  2001-04       Impact factor: 5.742

4.  Circulating protein synthesis rates reveal skeletal muscle proteome dynamics.

Authors:  Mahalakshmi Shankaran; Chelsea L King; Thomas E Angel; William E Holmes; Kelvin W Li; Marc Colangelo; John C Price; Scott M Turner; Christopher Bell; Karyn L Hamilton; Benjamin F Miller; Marc K Hellerstein
Journal:  J Clin Invest       Date:  2015-12-14       Impact factor: 14.808

5.  Changes in skeletal muscle gene expression following clenbuterol administration.

Authors:  Diane M Spurlock; Tara G McDaneld; Lauren M McIntyre
Journal:  BMC Genomics       Date:  2006-12-20       Impact factor: 3.969

6.  Mitochondrial phosphoenolpyruvate carboxykinase (PEPCK-M) and serine biosynthetic pathway genes are co-ordinately increased during anabolic agent-induced skeletal muscle growth.

Authors:  D M Brown; H Williams; K J P Ryan; T L Wilson; Z C T R Daniel; M H D Mareko; R D Emes; D W Harris; S Jones; J A D Wattis; I L Dryden; T C Hodgman; J M Brameld; T Parr
Journal:  Sci Rep       Date:  2016-06-28       Impact factor: 4.379

Review 7.  Common bean (Phaseolus vulgaris L.) α-amylase inhibitors as safe nutraceutical strategy against diabetes and obesity: An update review.

Authors:  Stefania Peddio; Alessandra Padiglia; Faustina B Cannea; Roberto Crnjar; Wissam Zam; Javad Sharifi-Rad; Antonio Rescigno; Paolo Zucca
Journal:  Phytother Res       Date:  2022-04-29       Impact factor: 6.388

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.